Brian Ackerman

NPI: 1235517913
Total Payments
$9,878
2024 Payments
$3,780
Companies
20
Transactions
433
Medicare Patients
290
Medicare Billing
$54,684

Payment Breakdown by Category

Food & Beverage$9,573 (96.9%)
Education$304.51 (3.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $9,573 428 96.9%
Education $304.51 5 3.1%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $1,810 83 $0 (2024)
Otsuka America Pharmaceutical, Inc. $1,301 43 $0 (2024)
Teva Pharmaceuticals USA, Inc. $1,090 61 $0 (2024)
ITI, Inc. $1,011 33 $0 (2023)
Alkermes, Inc. $950.28 50 $0 (2024)
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $711.43 21 $0 (2024)
Neurocrine Biosciences, Inc. $484.69 17 $0 (2024)
Lundbeck LLC $450.26 26 $0 (2024)
Janssen Pharmaceuticals, Inc $317.27 7 $0 (2024)
Vanda Pharmaceuticals Inc. $316.27 12 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $3,780 152 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($711.43)
2023 $3,305 162 ITI, Inc. ($550.04)
2022 $1,692 79 ABBVIE INC. ($622.76)
2021 $441.29 22 AbbVie Inc. ($153.28)
2020 $40.30 2 Janssen Pharmaceuticals, Inc ($21.00)
2019 $359.14 10 Janssen Pharmaceuticals, Inc ($197.12)
2018 $122.39 4 Alkermes, Inc. ($100.59)
2017 $137.09 2 Otsuka America Pharmaceutical, Inc. ($123.01)

All Payment Transactions

433 individual payment records from CMS Open Payments — Page 1 of 18

Date Company Product Nature Form Amount Type
12/20/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage In-kind items and services $23.08 General
Category: SCHIZOPHRENIA
12/18/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $24.77 General
Category: PSYCHIATRY
12/17/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $30.24 General
Category: NEUROSCIENCE
12/13/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $30.36 General
Category: NEUROSCIENCE
12/13/2024 Janssen Pharmaceuticals, Inc SPRAVATO (Drug) Food and Beverage In-kind items and services $27.90 General
Category: Neuroscience
12/13/2024 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $17.33 General
Category: Central Nervous System
12/10/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $31.94 General
Category: CNS
12/07/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $26.12 General
Category: PSYCHIATRY
12/05/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage In-kind items and services $17.69 General
Category: SCHIZOPHRENIA
12/05/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $15.35 General
Category: VILOXAZINE HYDROCHLORIDE
12/05/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $10.96 General
Category: PSYCHIATRY
12/03/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $20.19 General
Category: Psychiatry/Psychology
11/22/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $22.41 General
Category: NEUROSCIENCE
11/22/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage In-kind items and services $12.00 General
Category: SCHIZOPHRENIA
11/21/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $26.71 General
Category: Neuropsychiatry
11/21/2024 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $12.40 General
Category: PSYCHIATRY
11/19/2024 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $29.72 General
Category: CNS
11/15/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $22.74 General
Category: PSYCHIATRY
11/15/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $0.69 General
Category: PSYCHIATRY
11/14/2024 E.R. Squibb & Sons, L.L.C. COBENFY (Drug) Food and Beverage Cash or cash equivalent $84.23 General
Category: Psychiatry/Psychology
11/14/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $21.22 General
Category: NEUROSCIENCE
11/12/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $21.76 General
Category: NEUROSCIENCE
11/07/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage Cash or cash equivalent $124.74 General
Category: SCHIZOPHRENIA
11/07/2024 Neurocrine Biosciences, Inc. INGREZZA (Drug) Food and Beverage In-kind items and services $19.00 General
Category: Neuropsychiatry
11/03/2024 Supernus Pharmaceuticals, Inc. Qelbree (Drug) Food and Beverage In-kind items and services $18.09 General
Category: VILOXAZINE HYDROCHLORIDE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 98 391 $76,000 $24,771
2022 3 89 227 $50,737 $15,535
2021 3 49 101 $27,039 $7,899
2020 2 54 116 $28,363 $6,480
Total Patients
290
Total Services
835
Medicare Billing
$54,684
Procedure Codes
11

All Medicare Procedures & Services

11 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 41 191 $38,200 $13,644 35.7%
90833 Psychotherapy with evaluation and management visit, 30 minutes Office 2023 40 178 $31,150 $8,227 26.4%
90792 Psychiatric diagnostic evaluation with medical services Office 2023 17 22 $6,650 $2,899 43.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 43 139 $31,343 $9,593 30.6%
90833 Psychotherapy with evaluation and management visit, 30 minutes Office 2022 25 66 $11,550 $3,128 27.1%
90792 Psychiatric diagnostic evaluation with medical services Office 2022 21 22 $7,844 $2,814 35.9%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 24 69 $17,955 $5,168 28.8%
90792 Psychiatric diagnostic evaluation with medical services Office 2021 13 14 $4,872 $2,047 42.0%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 12 18 $4,212 $682.80 16.2%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 28 53 $13,621 $3,268 24.0%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 26 63 $14,742 $3,212 21.8%

About Brian Ackerman

Brian Ackerman is a Psychiatry healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/13/2015. The National Provider Identifier (NPI) number assigned to this provider is 1235517913.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brian Ackerman has received a total of $9,878 in payments from pharmaceutical and medical device companies, with $3,780 received in 2024. These payments were reported across 433 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($9,573).

As a Medicare-enrolled provider, Ackerman has provided services to 290 Medicare beneficiaries, totaling 835 services with total Medicare billing of $54,684. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.

Practice Information

  • Specialty Psychiatry
  • Location Providence, RI
  • Active Since 05/13/2015
  • Last Updated 08/06/2015
  • Taxonomy Code 2084P0800X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1235517913

Products in Payments

  • VRAYLAR (Drug) $1,810
  • CAPLYTA (Drug) $1,722
  • REXULTI (Drug) $1,247
  • ARISTADA (Drug) $804.74
  • INGREZZA (Drug) $484.69
  • Austedo XR (Drug) $379.08
  • AUSTEDO (Drug) $323.92
  • FANAPT (Drug) $316.27
  • TRINTELLIX (Drug) $278.39
  • INVEGA SUSTENNA (Drug) $229.94
  • NUEDEXTA (Drug) $220.61
  • Auvelity (Drug) $216.98
  • LATUDA (Drug) $198.54
  • JORNAY PM (Drug) $193.69
  • UZEDY (Drug) $184.48
  • QUVIVIQ (Drug) $155.91
  • ABILIFY MAINTENA (Drug) $146.63
  • COBENFY (Drug) $126.28
  • ABILIFY ASIMTUFII (Drug) $119.57
  • Azstarys (Drug) $94.59

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatry Doctors in Providence